International Clinical Trial: Safety and Efficacy Study of Nucleic Acid Decoy decoy-RORa-Loaded Controlled-Release Microneedles for Immune-Mediated Neuropathy - A Multicenter, Prospective, Open-Label, Single-Arm, Dose-Escalating Exploratory Phase I Medical Device Clinical Trial

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134637) titled 'Safety and Efficacy Study of Nucleic Acid Decoy decoy-RORa-Loaded Controlled-Release Microneedles for Immune-Mediated Neuropathy - A Multicenter, Prospective, Open-Label, Single-Arm, Dose-Escalating Exploratory Phase I Medical Device Clinical Trial' on Oct. 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: 925th Hospital of Joint Logistics Support Force

Condition: Immune Mediated Neuropathy,IMN

Intervention: Expand the sample group:Transdermal application of nucleic acid decoy decoy-RORa-loaded controlled-release microneedles combined with disease-specific standard immunotherapy...